Pfizer Inc
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters Only around one-third of patients prescribed weight loss drugs such as Novo Nordisk‘s blockbuster injection Wegovy continued to take it a year later — but total health-care costs […]
Read More
Novavax stock spikes 20% after company snags $350 million from Canada for unused Covid shots
Nikos Pekiaridis | Nurphoto | Getty Images Stock Chart IconStock chart icon Novavax shares jump on news of a settlement payment from the Canadian government. It’s unclear how many doses of Novavax’s jab – its only commercially available product after 35 years – went unused. Under the amended agreement, Novavax will also provide Canada with […]
Read More
A.I. could mean a ‘decade of health care is upon us.’ Here are some stock picks
Investors hoping to capture more upside from artificial intelligence could turn to a sector that’s underperformed this year, and maybe not immediately associated with AI: Health care. A handful of large tech names surged in the first half thanks to a mania for all things tied to artificial intelligence. Apple, for example, last week closed […]
Read More
Moderna strikes deal to develop mRNA drugs in China
Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Wednesday said it struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country, despite rising tensions between the U.S. and China. The Massachusetts-based biotech company signed a memorandum of understanding and a related land collaboration deal to develop drugs […]
Read More
Ex-Pfizer employee charged with illegal trading based on unreleased Covid pill trial data
Federal authorities charged a former Pfizer employee and his close friend Thursday with illegally trading shares based on non-public trial results on the pharmaceutical company’s Covid antiviral pill Paxlovid. The Justice Department and the Securities and Exchange Commission both announced respective insider trading charges against Amit Dagar, a former senior statistical programming lead at Pfizer, […]
Read More
Feds charge a few with unlawful trading ahead of Trump Media merger announcement
The previous US President declared his intention to develop a new social media system following he was banned from Fb and Twitter past 12 months. Leon Neal | Getty Illustrations or photos WASHINGTON — Three people today have been billed with illegally investing shares in a shell enterprise ahead of the announcement that it planned […]
Read More
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
Respiratory syncytial virus vial. Manjurul | Istock | Getty Images The Centers for Disease Control and Prevention on Thursday recommended that adults ages 60 and above receive a single dose of RSV vaccines from Pfizer and GSK after consulting their doctors. Outgoing CDC Director Rochelle Walensky signed off on the recommendation, which an advisory panel […]
Read More
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
An Eli Lilly & Co. logo is seen on a box of insulin medication in this arranged photograph at a pharmacy in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Drugmakers are jockeying to capitalize on the next major innovation coming to the blockbuster weight loss industry: effective, convenient and potentially affordable obesity pills. […]
Read More
Stocks earning the biggest moves midday: Pfizer, Lucid, WSFS Fiscal and more
Budrul Chukrut | Lightrocket | Getty Images Look at out the organizations producing headlines in midday investing. Lucid Team — Lucid shares jumped 9% just after the electrical-automobile maker stated it will provide powertrain and battery programs to British luxury automaker Aston Martin. WSFS Economic — The regional bank additional 4.4% after D.A. Davidson upgraded […]
Read More
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Novo Nordisk said that it was cutting the supply of some doses of its popular obesity drug in the U.S. as it struggles to keep up with surging demand. Liselotte Sabroe | Afp | Getty Images Novo Nordisk‘s high-dose experimental obesity pill helped overweight or obese adults lose around 15% of their body weight, according […]
Read More